Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1AARTI PHARMALABS LIMITED Mulund (W), Mumbai IN

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothAarti Pharmalabs is a partner of choice for APIs & Intermediates and the largest Indian manufacturer of Xanthine Derivatives.

R1-CEP 2008-239 - Rev 04
Valid
Chemical
2022-10-14
1765
Aarti Industries Company Banner

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothAarti Pharmalabs is a partner of choice for APIs & Intermediates and the largest Indian manufacturer of Xanthine Derivatives.

Certificate Number : R1-CEP 2008-239 - Rev 04

Status : Valid

Issue Date : 2022-10-14

Type : Chemical

Substance Number : 1765

Aarti Industries Company Banner

Looking for Certificates of Suitability (CEPs) for R1-CEP 2008-239 - Rev 04 of Aarti Pharmalabs Limited Mulund (w), Mumbai In

Looking for Certificates of Suitability (CEPs) for R1-CEP 2008-239 - Rev 04 of Aarti Pharmalabs Limited Mulund (w), Mumbai In 1

20

Aarti Pharmalabs Limited Mulund (w), Mumbai In, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

They are recognized for Aarti Pharmalabs is a partner of choice for APIs & Intermediates and the largest Indian manufacturer of Xanthine Derivatives.

One of their significant offerings is Salmeterol xinafoate, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2008-239 - Rev 04

This Chemical Type CEP, issued on October 14, 2022, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.

Substance Number 1765 associated with this CEP further emphasizes